| Acupuncture: could it become everyday practice in oncology? A Kilian-Kita, M Puskulluoglu, K Konopka, K Krzemieniecki Contemporary Oncology/Współczesna Onkologia 20 (2), 119-123, 2016 | 49 | 2016 |
| Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative … S Ochenduszko, M Puskulluoglu, K Konopka, K Fijorek, K Urbanczyk, ... Medical Oncology 32, 1-8, 2015 | 36 | 2015 |
| Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic—comprehensive recommendations of the Polish Society of Clinical Oncology PJ Wysocki, Ł Kwinta, P Potocki, K Konopka, J Streb, MZ Wojtukiewicz, ... Oncology in Clinical Practice 16 (2), 41-51, 2020 | 16 | 2020 |
| Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature J Streb, M Püsküllüoğlu, I Glanowska, S Ochenduszko, K Konopka, ... Oncology Letters 10 (6), 3749-3755, 2015 | 15 | 2015 |
| Metronomic chemotherapy based on topotecan or topotecan and cyclophosphamide combination (CyTo) in advanced, pretreated ovarian cancer PJ Wysocki, M Łobacz, P Potocki, Ł Kwinta, A Michałowska-Kaczmarczyk, ... Cancers 15 (4), 1067, 2023 | 14 | 2023 |
| Combined neutrophil-to-lymphocyte and platelet-volume-to-platelet ratio (NLR and PVPR score) represents a novel prognostic factor in advanced gastric cancer patients K Konopka, A Micek, S Ochenduszko, J Streb, P Potocki, Ł Kwinta, ... Journal of clinical medicine 10 (17), 3902, 2021 | 11 | 2021 |
| Metronomic chemo-endocrine therapy (FulVEC) as a Salvage treatment for patients with advanced, treatment-refractory ER+/HER2-Breast cancer—a retrospective analysis of … A Buda-Nowak, Ł Kwinta, P Potocki, A Michałowska-Kaczmarczyk, ... Journal of Clinical Medicine 12 (4), 1350, 2023 | 9 | 2023 |
| Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study S Ochenduszko, M Puskulluoglu, K Konopka, K Fijorek, AJ Slowik, ... Therapeutic Advances in Medical Oncology 9 (4), 223-233, 2017 | 7 | 2017 |
| Evaluation of health-related quality of life and its main influencing factors in a Polish population of patients with bone metastases M Püsküllüoğlu, AL Zygulska, IM Tomaszewska, S Ochenduszko, ... Current Problems in Cancer 40 (5-6), 183-197, 2016 | 7 | 2016 |
| Zalecenia postępowania diagnostyczno-terapeutycznego w raku nerkowokomórkowym—aktualizacja PJ Wysocki, P Chłosta, R Chrzan, A Czech, K Gronostaj, K Konopka, ... Onkologia w Praktyce Klinicznej-Edukacja 7 (4), 201-232, 2021 | 5 | 2021 |
| Polish Society of Clinical Oncology and Polish Urological Association Guidelines for the diagnosis and treatment of renal cell cancer PJ Wysocki, P Chłosta, R Chrzan, A Czech, K Gronostaj, K Konopka, ... Oncology in Clinical Practice 16 (6), 301-330, 2020 | 4 | 2020 |
| Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study PM Potocki, P Wójcik, Ł Chmura, B Goc, M Fedewicz, Z Bielańska, ... International Journal of Molecular Sciences 24 (10), 9073, 2023 | 3 | 2023 |
| Leczenie systemowe chorych na nowotwory lite w trakcie pandemii SARS-CoV-2—kompleksowe rekomendacje Polskiego Towarzystwa Onkologii Klinicznej PJ Wysocki, Ł Kwinta, P Potocki, K Konopka, J Streb, MZ Wojtukiewicz, ... Onkologia w Praktyce Klinicznej-Edukacja 6 (2), 57-68, 2020 | 3 | 2020 |
| Association of dietary intake of polyphenols, lignans, and phytosterols with immune-stimulating microbiota and COVID-19 risk in a group of Polish men and women A Micek, I Bolesławska, P Jagielski, K Konopka, A Waśkiewicz, ... Frontiers in Nutrition 10, 2023 | 2 | 2023 |
| Zalecenia postępowania diagnostyczno-terapeutycznego w raku nerkowokomórkowym PJ Wysocki, P Chłosta, R Chrzan, A Czech, K Gronostaj, K Konopka, ... Onkologia w Praktyce Klinicznej-Edukacja 6 (6), 407-437, 2020 | 2 | 2020 |
| Selective removal of soluble tumor necrosis factor receptors by apheresis as a novel immunotherapy approach for triple-negative breast cancer. A Ostrowski, R Segal, L Florin, N Anderson, VG Manax, A Marleau, ... Journal of Clinical Oncology 40 (16_suppl), e13065-e13065, 2022 | 1 | 2022 |
| Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer K Konopka, P Frączek, M Lubaś, A Micek, Ł Kwinta, J Streb, P Potocki, ... Journal of Clinical Medicine 11 (5), 1213, 2022 | 1 | 2022 |
| Polish consensus on gastric cancer diagnosis and treatment–update 2022 P Richter, G Wallner, W Zegarski, M Sierżęga, P Kołodziejczyk, ... Nowotwory. Journal of Oncology 72 (5), 334-341, 2022 | 1 | 2022 |
| Preliminary data on antitumor activity of extracorporeal subtraction of soluble TNFRs to unleash the activity of endogenous TNFα combined with chemotherapy in treatment … PJ Wysocki, A Ostrowski, R Segal, P Potocki, KW Konopka, L Kwinta, ... Journal of Clinical Oncology 39 (15_suppl), e13052-e13052, 2021 | 1 | 2021 |
| Comparison of efficacy and tolerance of first-line palliative chemotherapy EOX and mDCF regimens in patients with locally advanced inoperable or metastatic gastric or … S Ochenduszko, K Konopka, M Puskulluoglu, K Urbanczyk, A Budzynski, ... Journal of Clinical Oncology 33 (3_suppl), 135-135, 2015 | 1 | 2015 |
